Analysts Set Integer Holdings Corporation (NYSE:ITGR) Price Target at $98.71

Shares of Integer Holdings Corporation (NYSE:ITGR) have received a consensus recommendation of “Hold” from the eleven analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, six have given a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $98.7143.

Several research firms have weighed in on ITGR. Wells Fargo & Company lifted their price objective on shares of Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, February 20th. Citigroup lifted their price objective on shares of Integer from $89.00 to $92.00 and gave the stock a “neutral” rating in a research report on Thursday, May 28th. Weiss Ratings upgraded shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, February 24th. Truist Financial lifted their price objective on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Friday, February 20th. Finally, Zacks Research cut shares of Integer from a “hold” rating to a “strong sell” rating in a research report on Monday, May 11th.

Integer Trading Up 0.9%

Integer stock opened at $92.22 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75. The firm has a market cap of $3.13 billion, a price-to-earnings ratio of 23.00, a price-to-earnings-growth ratio of 2.18 and a beta of 0.66. Integer has a 1 year low of $62.00 and a 1 year high of $123.78. The firm’s 50 day moving average price is $88.36 and its two-hundred day moving average price is $84.08.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.01). The business had revenue of $439.58 million during the quarter, compared to analyst estimates of $426.48 million. Integer had a return on equity of 12.83% and a net margin of 7.64%.The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. On average, research analysts predict that Integer will post 6.04 EPS for the current fiscal year.

Hedge Funds Weigh In On Integer

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC grew its position in Integer by 48.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 117 shares in the last quarter. Salomon & Ludwin LLC boosted its stake in shares of Integer by 46.8% during the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 118 shares during the period. TD Private Client Wealth LLC boosted its stake in shares of Integer by 1,037.5% during the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after buying an additional 415 shares during the period. Parkside Financial Bank & Trust boosted its stake in shares of Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after buying an additional 267 shares during the period. Finally, Arax Advisory Partners boosted its stake in shares of Integer by 2,489.5% during the 4th quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 473 shares during the period. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.